Cite Filings / ONC / 9999999995-25-000604
Feed Companies Filings Check
Sign in
EFFECT

Notice of Effectiveness

BeOne Medicines Ltd. · Filed 2025-03-07 · Acc 9999999995-25-000604

Documents 1

  • EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

  • 2025-05-23 EFFECT Notice of Effectiveness
  • 2025-03-07 EFFECT Notice of Effectiveness
  • 2025-03-07 4 Chief Executive Officer sold 58,590 shares at an average $249.13 ($14,596,247)
  • 2025-03-07 4 Chief Executive Officer sold 40,109 shares at an average $259.15 ($10,394,329)
  • 2025-03-07 4 President, COO & GM China sold 51,921 shares at an average $261.59 ($13,581,905)
  • 2025-03-07 4 Global Head of R&D acquired 69,251 shares (grant or award)
  • 2016-11-17 EFFECT Notice of Effectiveness

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…